A single dose of the LSD-based therapy DT120 produced rapid antidepressant effects that remained significant through 12 weeks in a pivotal phase 3 trial of major depressive disorder.
Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing ...
People taking Definium Therapeutics' DT120 showed long-lasting reductions in their depression symptoms compared to a placebo, ...
By Kamal Choudhury June 22 (Reuters) - Definium Therapeutics said a single dose of its LSD-based experimental pill ...
A single 100-microgram dose of DT120 produced rapid and lasting antidepressant effects that were significantly better than ...
A proof-of-concept study suggests the 5-HT4 receptor agonist prucalopride, which is approved for chronic constipation, ...
Definium Therapeutics surged ~50% after positive Phase 3 EMERGE data for DT120 in major depressive disorder, demonstrating ...
Such brain imaging helped researchers better target accelerated transcranial magnetic stimulation (aTMS), producing a ...
USA News Group News Commentary, In drug development, enrollment is the quiet variable that decides whether a promising therapy ever reaches a ...
28d
Single infusion of controversial drug changed severe depression symptoms within hours, study finds
Researchers say a single intravenous ketamine infusion can rapidly relieve severe depression and suicidal thoughts when ...
Definium Therapeutics said a single dose of its LSD-based experimental pill significantly reduced symptoms of major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results